UBS Group
NGC.U

UBS Group’s Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant NGC.U Stock Holding History

UBS Group’s Portfolio NGC.U Stock Details NGC.U Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,751
Closed -$17.5K – 11269
2022
Q4 		$17.5K Sell
1,751
-2,594
-60% -$25.7K ﹤0.01% 7820
2022
Q3 		$43K Buy
4,345
+2,968
+216% +$29.2K ﹤0.01% 6508
2022
Q2 		$13K Buy
1,377
+24
+2% +$237 ﹤0.01% 7606
2022
Q1 		$13K Buy
1,353
+48
+4% +$475 ﹤0.01% 8117
2021
Q4 		$13K Hold
1,305
– – ﹤0.01% 8511
2021
Q3 		$13K Sell
1,305
-1,745
-57% -$17.6K ﹤0.01% 7712
2021
Q2 		$31K Buy
+3,050
New +$30.8K ﹤0.01% 6912

UBS Group's NGC.U Position: Q1 2023 in Review

UBS Group sold out of Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant (NGC.U) in Q1 2023, closing a stake of 1,751 shares — an estimated $17.5K sold.

UBS Group first reported a position in NGC.U in Q2 2021 and held it in 7 quarters. The position peaked at $43K in Q3 2022. 0 funds tracked by Wall St. Rank hold NGC.U as of Q1 2023.

  • UBS Group reported no remaining Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 1,751 Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant shares in Q1 2023, an estimated $17.5K.
  • UBS Group first reported a position in Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant in Q2 2021 and held it in 7 quarters.
  • UBS Group's Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant position peaked at $43K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.